Business Wire

U.S. FCC Expands Market Access for SES O3b MEO Constellation

Del

SES announced today that it has been granted, by the U.S. Federal Communications Commission (FCC), authorization to serve the U.S. market using a significantly expanded O3b fleet in the Medium Earth Orbit (MEO).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180607006386/en/

U.S. FCC Expands Market Access for SES O3b MEO Constellation (Photo: Business Wire)

U.S. FCC Expands Market Access for SES O3b MEO Constellation (Photo: Business Wire)

The FCC grant opens significant additional frequencies to SES for use in its non-geostationary (NGSO) constellation and enables it to deploy O3b mPOWER satellites into inclined and equatorial orbits, delivering full global pole-to-pole coverage. A total of 26 new O3b satellites are authorized, in addition to the 16 satellites already operational and in orbit. The grant allows SES to add 4 satellites to its existing O3b constellation, which are scheduled for launch next year, and provides the framework for SES to triple its next-generation O3b mPOWER fleet by giving U.S. market access for another 22 super-powered satellites, of which 7 are currently under construction and scheduled for launch starting in 2021.

The O3b mPOWER constellation will bring massive scale and flexibility to the proven O3b MEO model. The 7 O3b mPOWER MEO satellites that SES has ordered already will have more than 30,000 dynamic, electronically-generated, fully-shapeable and steerable beams that can be shifted and switched in real time following customers’ needs. Each satellite boasts more than 10 times the capability of the current O3b satellites with unmatched flexibility.

“This important FCC grant provides SES with the means to grow and scale our network, connecting the planet and delivering world class solutions to our customers globally,” said Steve Collar, President and CEO of SES. “With the first 7 O3b mPOWER satellites, we will deliver a paradigm shift in performance, bandwidth and service. The FCC grant provides the platform to exponentially scale the network in response to surging demand for global data connectivity.”

The O3b fleet is the only NGSO system delivering fibre-like broadband services today. O3b mPOWER, when launched, will enable an even wider array of industries and customers to tap into this high-performance connectivity.

Follow us on:

Social Media
Blog
Media Library
White Papers

About SES

SES is the world-leading satellite operator with a fleet of over 70 satellites, of which more than 50 in Geostationary Earth Orbit (GEO) and 16 in Medium Earth Orbit (MEO). SES’ two key business units, SES Video and SES Networks, deliver powerful end-to-end and customer focused solutions reaching over one billion people every day, connecting and empowering broadcasters, telecom, businesses and governments across the world. SES’ flexible networks enable applications in domains such as aeronautical, maritime and cellular networks as well as government and institutional operations, powering the development of global connectivity. SES’ portfolio includes MX1, a leading media service provider that offers a full suite of innovative digital video and media services and GovSat, a 50/50 public-private partnership between SES and the Luxembourg government. SES is listed on the Euronext Paris and Luxembourg Stock Exchange (SESG). Further information available at: www.ses.com

Contact information

SES
Markus Payer
Corporate Communications & PR
Tel. +352 710 725 500
Markus.Payer@ses.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

American Express Wins Major Antitrust Lawsuit25.6.2018 18:05Pressemelding

American Express (NYSE:AXP) issued the following statement today from Chairman and CEO Stephen J. Squeri regarding the U.S. Supreme Court’s decision in the Department of Justice’s antitrust lawsuit: “The Court’s decision is a major victory for consumers and for American Express. “This was a long battle, but well worth the fight because important issues were at stake: consumer choice, fair market competition, and the ability to deliver innovative products and services to our customers, both consumers and merchants. “As the Supreme Court stated today, ‘…Amex’s business model has stimulated competitive innovations in the credit-card market, increasing the volume of transactions and improving the quality of the services.’ “Since this case started eight years ago, we have significantly expanded the network of merchants who willingly accept American Express, and have seen merchant satisfaction steadily increase. We have also broadened the range of benefits, services and experiences that buil

Synteract Announces Collaboration with International Children’s Advisory Network iCAN Research25.6.2018 17:03Pressemelding

Synteract, an innovative contract research organization (CRO) providing full, phase I-IV services enabling drug development companies to bring new medicines to market, has signed a memo of understanding to partner with the International Children’s Advisory Network (iCAN). A worldwide consortium of children’s advisory groups, iCAN is dedicated to giving children and families a voice in health, medicine, research, and innovation by increasing education about the importance of children’s involvement. Synteract is a sponsor at the 2018 iCAN Research Summit in Edinburgh, Scotland, UK, July 8-13, 2018 and will hold two interactive plenary seminar sessions at the event. With chapters across the U.S. and worldwide, iCAN partners with local children’s hospitals and addresses the needs of pediatric clinical research and healthcare and advocates for patients worldwide. In partnering with iCAN, Synteract will expand its access to children and families familiar with clinical research. iCAN will sup

GA-ASI to Fly First Trans-Atlantic Flight of a MALE RPA25.6.2018 16:55Pressemelding

On July 10-11, General Atomics Aeronautical Systems, Inc. (GA-ASI) plans to make the first-ever trans-Atlantic flight of a Medium-altitude, Long-endurance (MALE) Remotely Piloted Aircraft (RPA). GA-ASI’s company-owned MQ-9B SkyGuardian RPA is scheduled to fly from the company’s Flight Test and Training Center in Grand Forks, North Dakota, USA, to Royal Air Force (RAF) Fairford in Gloucestershire, UK. The aircraft will then be on static display July 13-15 for the Royal International Air Tattoo (RIAT) airshow being held at RAF Fairford. The flight and display will commemorate the RAF’s centenary celebration (RAF100). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180625005946/en/ GA-ASI’s company-owned MQ-9B SkyGuardian RPA is scheduled to fly from the company’s Flight Test and Training Center in Grand Forks, North Dakota, USA, to Royal Air Force (RAF) Fairford in Gloucestershire, UK. The aircraft will then be on static displa

Quadient Announces General Availability of Quadient Inspire R1225.6.2018 14:30Pressemelding

www.quadient.com : Quadient, the award-winning leader in Customer Communications Management (CCM), announced the general availability of its newest release, Quadient Inspire R12, which includes the new Digital Advantage Suite. The updated version of Quadient Inspire is designed to give customers and partners greater control over the systems and processes used to drive consistent communications across all channels with an emphasis on digital experiences. With Inspire R12, users design omni-channel communications in days rather than months with a simple, modern and comprehensive platform. The solution makes it possible to change designs and test for all channels in minutes, with fully integrated tracking and approval processes built in. Additionally, R12 integrates all parts of the communications process from linking journey maps to communications, postal sorting, address, phone and email verifications, email delivery, SMS delivery, mail delivery tracking, and production monitoring to re

The Dementia Discovery Fund Raises $350 Million25.6.2018 13:00Pressemelding

The Dementia Discovery Fund (DDF) today announces the completion of its fundraising, with £250 million ($350 million at the time of completion) raised from an influential group of strategic investors committed to developing new medicines for dementia. The goal was met today with a new investment of $60 million from US AARP, the global nonpartisan organisation dedicated to empowering Americans 50 and older to choose how they live as they age. The fundraising far exceeded its initial target of $200 million (£130 million), making it the first and largest venture fund focused entirely on discovering and developing novel therapies for dementia, including Alzheimer’s disease. The DDF makes early stage venture capital investments to develop novel disease-modifying therapeutics for all forms of dementia. The fund is managed by SV Health and was formed through the collaboration of leading pharmaceutical companies (Biogen, Eli Lilly and Company, GSK, Johnson & Johnson, Otsuka (Astex), Pfizer and

Professor Thierry Philip Takes Office as OECI President25.6.2018 12:22Pressemelding

Professor Thierry Philip, President of the Institut Curie, has been elected President of the Organisation of European Cancer Institutes ( OECI ) for a three-year term. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180625005600/en/ Pr Thierry Philip (Photo: Business Wire) At the end of June 2018, Professor Philip, an oncologist and pediatrician, will take over as head of this European organization, which brings together 90 institutes and university centers and whose mission is fully devoted to cancer. This European non-governmental, non-profit organization aims to promote cooperation between its members or associate members and pursues a triple objective: to provide cancer patients in Europe with equal access to high-quality care; to assist European institutes with the implementation of a quality system for oncology care; to promote and accelerate the progress of translational research. In this regard, half of the 90 OECI ce